Drug Type Recombinant protein |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bladder Cancer | Preclinical | US | - | |
Breast Cancer | Preclinical | US | - | |
Colonic Cancer | Preclinical | US | - | |
Glioblastoma | Preclinical | US | - | |
Graft vs Host Disease | Preclinical | US | - | |
Head and Neck Neoplasms | Preclinical | US | - | |
Kidney Neoplasms | Preclinical | US | - | |
Lung Cancer | Preclinical | US | - | |
Melanoma | Preclinical | US | - | |
Prostatic Cancer | Preclinical | US | - |